Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

COVID-19-associated Pulmonary Aspergillosis: A New Entity

Journal of Mycology and Infection 2021³â 26±Ç 2È£ p.23 ~ 27
¼­Çö¹Î, ¹ÚÁöÈÆ, ¿À¼¼¿í, ¹Ú¼¼±¤, ±èÁ¤¼ö,
¼Ò¼Ó »ó¼¼Á¤º¸
¼­Çö¹Î ( Seo Hyun-Min ) 
Hanyang University Guri Hospital Department of Dermatology

¹ÚÁöÈÆ ( Park Ji-Hun ) 
Hanyang University Guri Hospital Department of Dermatology
¿À¼¼¿í ( Oh Se-Uk ) 
Hanyang University Guri Hospital Department of Dermatology
¹Ú¼¼±¤ ( Park Se-Kwang ) 
Hanyang University Guri Hospital Department of Dermatology
±èÁ¤¼ö ( Kim Joung-Soo ) 
Hanyang University Guri Hospital Department of Dermatology

Abstract


In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. This resulted in the discovery of a new clinical Aspergillus disease phenotype, COVID-19-associated pulmonary aspergillosis. This review aimed to collect and share clinical experiences from this new disease.

Ű¿öµå

Aspergillosis; COVID-19; Deep fungal infection; Fungus; SARS-CoV-2

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸